Pediatric Pertussis in Ambulatory Settings
Eligible age
0–18 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
You may qualify if…
- ✓ All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested
You may not qualify if…
- ✕ children without symptoms with a household confirmed case
- ✕ cases for which the pertussis diagnosis was not suspected by the pediatrician
Source: ClinicalTrials.gov · NCT04807712 · last updated 2024-02-08